Saxagliptin + Metformin


( Last Updated : August 23, 2013)
Generic Name:
Saxagliptin + metformin
Project Status:
Complete
Therapeutic Area:
Diabetes Mellitus, type 2
Manufacturer:
AstraZeneca Canada Inc.
Call for patient/clinician input open:
Brand Name:
Komboglyze
Project Line:
Reimbursement Review
Project Number:
SR0348-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Diabetes Mellitus, Type 2
Recommendation Type:
List with criteria/condition
Final Recommendation: